SIRT-2 inhibitors (NHLBI)

N/A

Report date: 2025/03/20 09:22:56

Base Information

Drug NameSIRT-2 inhibitors (NHLBI)
Drug Alias NameSirtuin-2 inhibitors (NHLBI)
ClassificationBiologics
Mechanisms of ActionNAD-dependent protein deacetylase sirtuin-2 inhibitors
TargetsNAD-dependent protein deacetylase sirtuin-2
Therapy Area/IndicationsIschemic StrokeNecrosisMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Heart, Lung And Blood Institute
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of HealthNational Heart, Lung And Blood Institute
Inactive CompaniesN/A
Active IndicationsIschemic StrokeNecrosisMyocardial Infarction
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A